Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph early_phase_1
2
50%
Ph phase_1
2
50%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 1Safety & dosage
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting2
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Early Phase 12 (50.0%)
Phase 12 (50.0%)

Trials by Status

not_yet_recruiting125%
enrolling_by_invitation125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingearly_phase_1

Implantable Microdevice In Primary Brain Tumors

NCT04135807
recruitingphase_1

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT04701645
not_yet_recruitingearly_phase_1

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

NCT06782399
enrolling_by_invitationphase_1

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

NCT04399876

Clinical Trials (4)

Showing 4 of 4 trials
NCT04135807Early Phase 1

Implantable Microdevice In Primary Brain Tumors

Recruiting
NCT04701645Phase 1

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Recruiting
NCT06782399Early Phase 1

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

Not Yet Recruiting
NCT04399876Phase 1

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

Enrolling By Invitation

All 4 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
4